Article | Published:

Sex differences in the awareness, treatment, and control of hypertension in China: a systematic review with meta-analyses

Hypertension Research (2018) | Download Citation

Subjects

Abstract

Hypertension is the major cause of preventable disease burden in China. However, limited evidence is available on sex differences in the awareness, treatment, and control of hypertension. We assessed sex differences in the awareness, treatment, and control of hypertension in China. A systematic search of four English language and four Chinese-language databases was conducted to identify studies conducted from 2005 that reported sex-specific data on the awareness, treatment, and control of hypertension in China. Random-effects meta-analysis weighted by the inverse of the variances were used to obtain pooled sex-specific rates and women-minus-men differences, and their 95% confidence intervals (CI). Overall, 57 studies comprising 2,155,829 individuals (55% women) were included. Awareness (53% in women vs. 47% in men), treatment among all (44% vs. 38%), treatment among aware (65% vs. 60%), control among all (17% vs. 14%), and control among treated (27% vs. 27%) were low for both sexes, but more favourable in women than men. The corresponding women-minus men difference was 7% (95% CI: 6; 8%) for awareness, 6% (5; 8%) for treatment among all, 6% (2; 9%) for treatment among aware, 3% (2; 3%) for control among all, and 0% (−2; 1%) for control among treated. Awareness, treatment, and control of hypertension in China is low in both sexes, but greater in women than men. Sex-specific interventions may be needed to efficiently combat the burden of hypertension.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37–55.

  2. 2.

    World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013-20. Geneva, Switzerland: World Health Organization; 2013.

  3. 3.

    NCD Risk Factor Collaboration. 2017. http://www.ncdrisc.org/index.html (accessed 10-11-2017)

  4. 4.

    Lu J, Lu Y, Wang X, Li X, Linderman G and Wu C. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390:2549–58.

  5. 5.

    Su M, Zhang Q, Bai X, Wu C, Li Y and Mossialos E. Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey. Lancet. 2017;390:2559–68.

  6. 6.

    Li Y, Yang L, Wang L, Zhang M, Huang Z, Deng Q, et al. Burden of hypertension in China: a nationally representative survey of 174,621 adults. Int J Cardiol. 2017;227:516–23.

  7. 7.

    Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043–50.

  8. 8.

    Gee ME, Campbell NR, Gwadry-Sridhar F, Nolan RP, Kaczorowski J, Bienek A, et al. Antihypertensive medication use, adherence, stops, and starts in Canadians with hypertension. Can J Cardiol. 2012;28:383–9.

  9. 9.

    Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310:959–68.

  10. 10.

    Everett B, Zajacova A. Gender differences in hypertension and hypertension awareness among young adults. Biodemography Social Biol. 2015;61:1–17.

  11. 11.

    Sarganas G, Neuhauser HK. The persisting gender gap in hypertension management and control in Germany: 1998 and 2008-11. Hypertens Res: Off J Jpn Soc Hypertens. 2016;39:457–66.

  12. 12.

    Zhang Y and Moran AE. Trends in the prevalence, awareness, treatment, and control of hypertension among young adults in the United States, 1999 to 2014. Hypertension. 2017;70:736-42.

  13. 13.

    Choi HM, Kim HC, Kang DR. Sex differences in hypertension prevalence and control: Analysis of the 2010-4 Korea National Health and Nutrition Examination Survey. PLoS ONE. 2017;12:e0178334.

  14. 14.

    Redfern A, Luo R, Cheng Y, Li Q, Wang H. A systematic review of access to care and quality of care for women with non-communicable diseases in China. PROSPERO 2016:CRD42016050415 2016. https://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016050415 (accessed 10-11-2017)

  15. 15.

    Gu Q, Burt VL, Paulose-Ram R, Dillon CF. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004. Am J Hypertens. 2008;21:789–98.

  16. 16.

    Daugherty SL, Masoudi FA, Ellis JL, Ho PM, Schmittdiel JA, Tavel HM, et al. Age-dependent gender differences in hypertension management. J Hypertens. 2011;29:1005–11.

  17. 17.

    Lewington S, Lacey B, Clarke R, Guo Y, Kong XL, Yang L, et al. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern Med. 2016;176:524–32.

  18. 18.

    Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract. 2000;49:147–52.

  19. 19.

    Turnbull F, Woodward M, Neal B, Barzi F, Ninomiya T, Chalmers J, et al. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J. 2008;29:2669–80.

  20. 20.

    Song Y, Bian Y, Petzold M, Li L, Yin A. The impact of China’s national essential medicine system on improving rational drug use in primary health care facilities: an empirical study in four provinces. BMC Health Serv Res. 2014;14:507.

Download references

Funding

This work was supported by a policy grant from the Oxford Martin School at the University of Oxford. SP is supported by a UK Medical Research Council Skills Development Fellowship (MR/P014550/1).

Author information

Author notes

  1. Joint first authors: Alice Redfern, Sanne A.E. Peters

  2. Joint senior authors: Haijun Wang, Robyn Norton

Affiliations

  1. The George Institute for Global Health, University of Oxford, Oxford, UK

    • Alice Redfern
    • , Sanne A. E. Peters
    •  & Robyn Norton
  2. The George Institute for Global Health, Peking University Health Science Center, Beijing, China

    • Rong Luo
    •  & Craig Anderson
  3. Department of Maternal and Child Health, School of Public Health, Peking University, Beijing, China

    • Yu Cheng
    • , Chenxiong Li
    •  & Haijun Wang
  4. Institute of Medical Humanities, Peking University Health Science Center, Beijing, China

    • Jiawen Wang
  5. The George Institute for Global Health, University of New South Wales, Sydney, Australia

    • Craig Anderson
    •  & Robyn Norton

Authors

  1. Search for Alice Redfern in:

  2. Search for Sanne A. E. Peters in:

  3. Search for Rong Luo in:

  4. Search for Yu Cheng in:

  5. Search for Chenxiong Li in:

  6. Search for Jiawen Wang in:

  7. Search for Craig Anderson in:

  8. Search for Haijun Wang in:

  9. Search for Robyn Norton in:

Conflict of interest

The authors declare that they have no conflict of interest.

Corresponding author

Correspondence to Sanne A. E. Peters.

Electronic supplementary material

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/s41440-018-0154-x